InvestorsHub Logo
Followers 20
Posts 1631
Boards Moderated 0
Alias Born 11/10/2010

Re: None

Tuesday, 09/05/2017 2:52:28 PM

Tuesday, September 05, 2017 2:52:28 PM

Post# of 592
Eagle Pharmaceuticals Announces Positive Results of Study Conducted to Evaluate Neuroprotective Effects of RYANODEX Secondary to Nerve Agent Exposure

http://investor.eagleus.com/press-release/eagle-pharmaceuticals-announces-positive-results-study-conducted-evaluate-neuroprotect

Eagle is going for a full on blockbuster drug with Ryanodex, just going to take some time.

Long term Eagle is undervalued here IMO, pemetrexed overhang currently keeping me out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EGRX News